Oxidized low-density lipoprotein stimulates endothelin-1 release and mRNA expression from rat mesangial cells

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 2, 1997, Pages 224-230

  Tan, Mian Shin ^a   Lee, Yau Jiunn ^a   Shin, Shyi Jang ^a   Tsai, Juei Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031079705     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90143-8     Document Type: Article

References (32)

1. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP. Hyperlipidemia and progressive renal disease. Kidney Int 1991;39(Suppl 31):S41-8.
2. Wheeler DC, Chana RS. Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 1993; 19:149-64.
3. Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 1993;22:72-82.
4. Guijarro C, Keane WF. Lipid-induced glomerular injury. Nephron 1994;67:1-6.
5. Bank N. Renal hemodynamic consequences of hyperlipidemia. Miner Electrolyte Metab 1993;19:165-72.
6. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, Keane WF. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 1990;37:880-91.
7. Wheeler DC, Chana RS, Topley N, Petersen MM, Davies M, Williams JD. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 1994; 45:1628-36.
8. Magil AB, Frohlich JJ, Innis SM, Steinbrecher UP. Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 1993;43:1243-50.
9. Bank N, Aynedjian HS. Role of thromboxane in impaired renal vasodilatation response to acetylcholine in hypercholesterolemic rats. J Clin Invest 1992;89:1636-42.
10. Chin JH, Azhar S, Huffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteines. J Clin Invest 1992;89:10-8.
11. Kohon DE. Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis 1993;22:493-510.
12. Simonson MS. Endothelins: multifunctional renal peptides. Physiol Rev 1993;73:375-411.
13. Simonson MS, Wann S, Mene P, et al. Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989;83:708-12.
14. Simonson MS, Dunn MJ. Endothelin peptides: a possible role in glomerular inflammation. Lab Invest 1991;64:1-4.
15. Latta H. An approach to the structure and function of the glomerular mesangium. J Am Soc Nephrol 1992;2:S65-73.
16. Gupta S, Rifici V, Crowley S, Brownlee M, Shan Z, Schlondorff D. Interactions of LDL and modified LDL with mesangial cells and matrix. Kidney Int 1992;41:1161-9.
17. Keane WF, O'Donnell MP, Kasiske BL, Kim Y. Oxidative modification of low-density lipoproteins by mesangial cells. J Am Soc Nephrol 1993;4:187-94.
18. Coritsidis G, Rifici V, Gupta S, et al. Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 1991;39:858-66.
19. Sakamoto H, Sasaki S, Hirata Y, et al. Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 1990;169:462-8.
20. Harper PA, Robinson JM, Hoover RL, Wright TC, Karnovsky MJ. Improved methods for culturing rat glomerular cells. Kidney Int 1984;26:875-80.
21. Tan M-S, Tsai J-C, Lee Y-J, et al. Induction of heparinbinding epidermal growth factor-like growth factor mRNA by protein kinase C activators. Kidney Int 1994;46:690-5.
22. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;43:1345-53.
23. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627-30.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. Lee Y-J, Shin S-J, Tsai J-H. Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 1994;17:263-6.
26. Tan M-S, Lee Y-J, Shin S-J, Tsai J-H. Regulation of heparin binding-epidermal growth factor gene expression by LDL and oxidized-LDL in rat mesangial cells. Biochem Biophys Res Commun 1994;202:1001-8.
27. Kaplan R, Aynedjian HS, Schlondorff D, Bank N. Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol. J Clin Invest 1990;86:1707-14.
28. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
29. Hirano T, Morohoshi T. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis. Nephron 1992;60:443-7.
30. Rayner HC, Ward L, Walls J. Cholesterol feeding following unilateral nephrectomy in the rat leads to glomerular hypertrophy. Nephron 1991;57:453-9.
31. Tolins JP, Stone BG, Raij L. Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury. Kidney Int 1992;41:1254-61.
32. Haaber AB, Kofoed-Enevoldsen A, Jensen T. The prevalence of hypercholesterolaemia and its relationship with albuminuria in insulin-dependent diabetic patients: an epidemiological study. Diabetic Med 1992;9:557-61.